<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04825769</url>
  </required_header>
  <id_info>
    <org_study_id>SHYB2021001</org_study_id>
    <nct_id>NCT04825769</nct_id>
  </id_info>
  <brief_title>Red Light Intervention for Myopia Prevention</brief_title>
  <official_title>A Multicenter Randomized Controlled Trial of Low-dose Single-wavelength Red Light in the Decrease of Myopia Incidence Rate in the Setting of School.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shanghai Eye Disease Prevention and Treatment Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Shanghai Eye Disease Prevention and Treatment Center</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To explore the effectiveness of using low-intensity single-wavelength red light to prevent&#xD;
      myopia in schoolchildren, and to provide a feasible scheme for reducing the incidence of&#xD;
      myopia.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 25, 2021</start_date>
  <completion_date type="Anticipated">March 25, 2022</completion_date>
  <primary_completion_date type="Anticipated">March 25, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>One-year cumulative incidence of myopia (%) in the intervention group and the control group.</measure>
    <time_frame>1 year</time_frame>
    <description>Myopia is defined as the cycloplegic spherical equivalent of either eye ≤-0.5D</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The progress of spherical equivalent(SE,D) of children in intervention group and control group.</measure>
    <time_frame>1 year</time_frame>
    <description>The spherical equivalent(SE,D) will be measured by autorefractor(KR-8900, Topcon).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The progress of axial length of children in intervention group and control group.</measure>
    <time_frame>1 year</time_frame>
    <description>The axial length will be measured using IOLMaster.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The progress of choroidal thickness in children in pre-myopia state in intervention group and control group.</measure>
    <time_frame>1 year</time_frame>
    <description>The choroidal thickness will be measured using SS-OCT.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The change of uncorrected visual acuity (UCVA) of children in intervention group and control group.</measure>
    <time_frame>1 year</time_frame>
    <description>The uncorrected visual acuity (UCVA) will be measured using a mounted and illuminated E chart of the Early Treatment Diabetic Retinopathy study (ETDRS) charts.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">534</enrollment>
  <condition>Myopia</condition>
  <arm_group>
    <arm_group_label>Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Red light irradiation was conducted at school from Monday to Friday and at home everyday in summer and winter holiday twice a day for 3 minutes per time, with an interval of 4 hours</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>No intervention</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>LLLT（Low Level Laser Therapy）</intervention_name>
    <description>2 times a day, 3 minutes each time, with an interval of more than 4 hours. During the semester: From Monday to Friday, set up an intervention room in the school; For winter and summer vacation: everyday at home</description>
    <arm_group_label>Intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Students of grade 1-4 in the participating schools;&#xD;
&#xD;
          -  Students' eyes have no myopia, that is the cycloplegic spherical equivalent（SE）&#xD;
             &gt;-0.50D, and at least one eye accords with the pre-myopic state, that is -0.50D&#xD;
             &lt;cycloplegic SE≤0.50D;&#xD;
&#xD;
          -  Students whose mother and/or father are in myopia status (SE &lt; -3.0D for either of&#xD;
             eyes);&#xD;
&#xD;
          -  Students whose parents sign informed consent and agree to let their kids participate&#xD;
             in baseline screen and follow-up examinations and surveys.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Students whose parents do not sign informed consent;&#xD;
&#xD;
          -  Students who have strabismus and/or other binocular vision abnormality;&#xD;
&#xD;
          -  Students who have other eye diseases and/or systematic diseases;&#xD;
&#xD;
          -  Students who meet the standards with which investigators and study physicians think it&#xD;
             is not appropriate to enroll.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>12 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Xiangui He</last_name>
    <role>Study Director</role>
    <affiliation>Shanghai Eye Disease Prevention and Treatment Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Xiangui He, PhD</last_name>
    <phone>15000755422</phone>
    <email>xianhezi@163.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Xiangui He</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200040</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xiangui He, MD</last_name>
      <phone>+8615000755422</phone>
      <email>xianhezi@163.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>March 24, 2021</study_first_submitted>
  <study_first_submitted_qc>March 29, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 1, 2021</study_first_posted>
  <last_update_submitted>August 11, 2021</last_update_submitted>
  <last_update_submitted_qc>August 11, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 13, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Children and adolescents</keyword>
  <keyword>Myopia</keyword>
  <keyword>Prevention and control</keyword>
  <keyword>Red light</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Myopia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>March 27, 2021</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/69/NCT04825769/Prot_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Statistical Analysis Plan</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>March 27, 2021</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/69/NCT04825769/SAP_001.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Informed Consent Form</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>March 27, 2021</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/69/NCT04825769/ICF_002.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

